Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Review

Anti-inflammatory properties of anesthetic agents

Authors: Fernanda Ferreira Cruz, Patricia Rieken Macedo Rocco, Paolo Pelosi

Published in: Critical Care | Issue 1/2017

Login to get access

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2017. Other selected articles can be found online at http://​ccforum.​com/​series/​annualupdate2017​. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://​www.​springer.​com/​series/​8901.
Literature
1.
2.
Colucci DG, Puig NR, Hernandez PR. Influence of anesthetic drugs on immune response: from inflammation to immunosuppression. OA Anesthetics. 2013;1:21–38.
3.
4.
Schneemilch CE, Schilling T, Bank U. Effects of general anaesthesia on inflammation. Best Pract Res Clin Anaesthesiol. 2004;18:493–507.CrossRefPubMed
5.
Elenkov IJ, Chrousos GP. Stress hormones, proinflammtory and anti-inflammatory cytokines, and autoimmunity. Ann NY Acad Sci. 2002;966:290–303.CrossRefPubMed
6.
Kennedy BC, Hall GM. Neuroendocrine and inflammatory aspects of surgery: do they affect outcome? Acta Anaesthesiol Belg. 1999;50:205–9.PubMed
7.
Graham EA. The influence of ether and ether anesthesia on bacteriolysis, agglutination and phagocytosis. J Infect Dis. 1911;8:147–75.CrossRef
8.
Amin OAI, Salah HE. The effect of general or spinal anaesthesia on pro- and anti-inflammatory intracellular cytokines in patients undergoing appendicectomy using flow cytometric method. Egypt J Anaesth. 2011;27:121–5.CrossRef
9.
Colucci D, Harvey G, Gayol MC, Elena G, Puig N. Halothane anesthesia in mice: effect on the phagocytic activity and respiratory burst of peritoneal macrophages. Neuroimmunomodulation. 2011;18:11–18.
10.
Simeonova GP, Slovov E, Usunov R, Halacheva K, Dinev DN. Increased apoptosis of peripheral blood mononuclear cells (PBMC) during general and epidural anaesthesia in dogs. Vet Res Commun. 2008;32:619–26.CrossRefPubMed
11.
Loix S, De Kock M, Henin P. The anti-inflammatory effects of ketamine: state of the art. Acta Anaesthesiol Belg. 2011;62:47–58.PubMed
12.
Welters ID, Hafer G, Menzebach A, et al. Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappab, Interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines. Anesth Analg. 2010;110:934–41.CrossRefPubMed
13.
Kock M, Loix S, Lavand’homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther. 2013;19:403–10.CrossRefPubMed
14.
15.
Memiş D, Hekimoğlu S, Vatan İ, Yandım T, Yüksel M. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth. 2007;98:550–2.CrossRefPubMed
16.
Zavala F, Haumont J, Lenfant M. Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol. 1984;106:561–6.CrossRefPubMed
17.
Nishina K, Akamatsu H, Mikawa K, et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg. 1998;86:159–65.PubMed
18.
Kim SN, Son SC, Lee SM, et al. Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology. 2006;105:105–10.CrossRefPubMed
19.
Frohlich D, Rothe G, Schwall B, et al. Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP. Eur J Anaesthesiol. 1996;13:582–8.CrossRefPubMed
20.
Jensen AG, Dahlgren C, Eintrei C. Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro. Br J Anaesth. 1993;70:99–100.CrossRefPubMed
21.
Mikawa K, Akamatsu H, Nishina K, et al. Propofol inhibits human neutrophil functions. Anesth Analg. 1998;87:695–700.PubMed
22.
Cleary TG, Pickering LK. Mechanisms of intralipid effect on polymorphonuclear leukocytes. J Clin Lab Immunol. 1983;11:21–6.PubMed
23.
Pirttinkangas CO, Perttila J, Salo M. Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients. Intensive Care Med. 1993;19:299–302.CrossRef
24.
Hoff G, Bauer I, Larsen B, Bauer M. Modulation of endotoxin-stimulated TNF-alpha gene expression by ketamine and propofol in cultured human whole blood. Anaesthesist. 2001;50:494–9.CrossRefPubMed
25.
Al-Hashimi M, Scott WM, Thompson JP, Lambert DG. Editor's choice: Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111:80–8.CrossRefPubMed
26.
Sacerdote P. Opioids and the immune system. Palliat Med. 2006;20:s9–s15.PubMed
27.
Hernandez M, Flores L, Bayer B. Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther. 1993;267:1336–41.PubMed
28.
Hall DM, Suo JL, Weber RJ. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J Neuroimmunol. 1998;83:29–35.CrossRefPubMed
29.
Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol. 2000;7:719–23.PubMedPubMedCentral
30.
Rittner HL, Brack A, Machelska H, et al. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology. 2001;95:500–8.CrossRefPubMed
31.
Jacobs R, Karst M, Scheinichen D, et al. Effects of fentanyl on cellular immune functions in man. Int J Immunopharmacol. 1999;21:445–54.CrossRefPubMed
32.
Sacerdote P, Gaspani L, Rossoni G, et al. Effect of the opioid remifentanil on cellular immune response in the rat. Int J Immunopharmacol. 2001;1:713–9.CrossRef
33.
Eberhardt KE, Thimm BM, Spring A, Maskos WR. Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study. Infection. 1992;20:12–8.CrossRefPubMed
34.
Chanimov M, Berman S, Weissgarten J, et al. Substances used for local and general anaesthesia in major surgery suppress proliferative responsiveness of normal rat peripheral blood mononuclear cells in culture. Eur J Anaesthes. 2000;17:248–55.CrossRef
35.
Cavalcanti V, Santos CL, Samary CS, et al. Effects of short-term propofol and dexmedetomidine on pulmonary morphofunction and biological markers in experimental mild acute lung injury. Respir Physiol Neurobiol. 2014;203:45–50.CrossRefPubMed
36.
Kang SH, Kim YS, Hong TH, et al. Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 2013;57:480–7.CrossRefPubMed
37.
Li B, Li Y, Tian S, et al. Anti-inflammatory effects of perioperative dexmedetomidine administered as an adjunct to general anesthesia: a meta-analysis. Sci Rep. 2015;5:12342.CrossRefPubMedPubMedCentral
38.
Yoon-Mi L, Byeng CS, Kyung-Jin Y. Impact of volatile anesthetics on oxidative stress and inflammation. Biomed Res Int. 2015;242709.
39.
40.
Cassuto J, Sinclair R, Bonderovic M. Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand. 2006;50:265–82.CrossRefPubMed
41.
Hahnenkamp K, Herroeder S, Hollmann MW. Regional anaesthesia, local anaesthetics and the surgical stress response. Best Pract Res Clin Anaesthesiol. 2004;18:509–27.CrossRefPubMed
42.
Toft P, Tønnesen E. The systemic inflammatory response to anaesthesia and surgery. Curr Anaesth Crit Care. 2008;19:349–53.CrossRef
43.
Homburger JA, Meiler SE. Anesthesia drugs, immunity, and long-term outcome. Curr Opin Anaesthesiol. 2006;19:423–8.CrossRefPubMed
44.
Vallejo R, Hord ED, Barna SA, Santiago-Palma J, Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol. 2003;22:139–46.CrossRefPubMed
45.
46.
Lassen HC, Henriksen E, Neukirch F, Kristensen HS. Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. Lancet. 1956;270:527–30.CrossRefPubMed
47.
Fellows IW, Byrne AJ, Allison SP. Adrenocortical suppression with etomidate. Lancet. 1983;2:54–5.CrossRefPubMed
Metadata
Title
Anti-inflammatory properties of anesthetic agents
Authors
Fernanda Ferreira Cruz
Patricia Rieken Macedo Rocco
Paolo Pelosi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-017-1645-x

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue

Research

Bronchoscopy versus an endotracheal tube mounted camera for the peri-interventional visualization of percutaneous dilatational tracheostomy - a prospective, randomized trial (VivaPDT)

Letter

Relapsing fever in young refugees from East Africa

Letter

Limited evidence to recommend against open chest cardiopulmonary resuscitation in blunt trauma

Research

Loxapine to control agitation during weaning from mechanical ventilation

Viewpoint

Optimal timing of renal replacement therapy initiation in acute kidney injury: the elephant felt by the blindmen?

Research

What is the impact of the fluid challenge technique on diagnosis of fluid responsiveness? A systematic review and meta-analysis